GSDMD and colitis: Accordingly, the administration of cGAS inhibitor RU.521 reduced weight loss, colon shortening, DAI score and histopathological findings in wild type murine models of DSS-induced colitis, totally rescuing the colitogenic phenotype in GSDMD-deficient mice.